Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 1
1982 1
1983 2
1984 2
1985 2
1988 1
1989 2
1991 5
1992 2
1993 7
1994 3
1996 5
1997 1
1998 5
1999 3
2000 7
2001 3
2002 5
2003 6
2004 2
2005 2
2006 3
2007 5
2008 8
2009 6
2010 9
2011 6
2012 4
2013 7
2014 16
2015 11
2016 7
2017 8
2018 6
2019 3
2020 6
2021 7
2022 8
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Thyroid Gland Anaplastic Carcinoma"
Page 1
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, Campbell M, Dickson P, Duh QY, Ehya H, Goldner WS, Guo T, Haymart M, Holt S, Hunt JP, Iagaru A, Kandeel F, Lamonica DM, Mandel S, Markovina S, McIver B, Raeburn CD, Rezaee R, Ridge JA, Roth MY, Scheri RP, Shah JP, Sipos JA, Sippel R, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Yeh M, Cassara CJ, Darlow S. Haddad RI, et al. J Natl Compr Canc Netw. 2022 Aug;20(8):925-951. doi: 10.6004/jnccn.2022.0040. J Natl Compr Canc Netw. 2022. PMID: 35948029
Anaplastic thyroid carcinoma is almost uniformly lethal, and iodine-131 imaging and radioactive iodine cannot be used. ...This article describes NCCN recommendations regarding management of medullary thyroid carcinoma and anaplastic th …
Anaplastic thyroid carcinoma is almost uniformly lethal, and iodine-131 imaging and radioactive iodine cannot be used. …
Thyroid carcinoma.
Sherman SI. Sherman SI. Lancet. 2003 Feb 8;361(9356):501-11. doi: 10.1016/s0140-6736(03)12488-9. Lancet. 2003. PMID: 12583960 Review.
Thyroid carcinomas are fairly uncommon and include disease types that range from indolent localised papillary carcinomas to the fulminant and lethal anaplastic disease. Several attempts to formulate a consensus about treatment of thyroid carcinoma have …
Thyroid carcinomas are fairly uncommon and include disease types that range from indolent localised papillary carcinomas to the fulmi …
Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P, Ferrari SM, Galdiero MR, Varricchi G, Elia G, Ragusa F, Paparo SR, Benvenga S, Antonelli A. Fallahi P, et al. Semin Cancer Biol. 2022 Feb;79:180-196. doi: 10.1016/j.semcancer.2020.11.013. Epub 2020 Nov 26. Semin Cancer Biol. 2022. PMID: 33249201 Review.
Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising incidence in the past 20 years. ...In DTC patients, radioactive iodine (RAI) is administered after thyroidectomy. Neck ultrasound, basal and thyroid-stimulating hormone-stimul …
Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising incidence in the past 20 years. ...In DTC …
Follicular cell-derived thyroid cancer.
Dralle H, Machens A, Basa J, Fatourechi V, Franceschi S, Hay ID, Nikiforov YE, Pacini F, Pasieka JL, Sherman SI. Dralle H, et al. Nat Rev Dis Primers. 2015 Dec 10;1:15077. doi: 10.1038/nrdp.2015.77. Nat Rev Dis Primers. 2015. PMID: 27188261 Review.
Follicular cell-derived thyroid cancers can be classified into papillary thyroid cancer (80-85%), follicular thyroid cancer (10-15%), poorly differentiated thyroid cancer (<2%) and undifferentiated (anaplastic) thyroid cancer (<2%), …
Follicular cell-derived thyroid cancers can be classified into papillary thyroid cancer (80-85%), follicular thyroid ca …
Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.
Smallridge RC, Copland JA. Smallridge RC, et al. Clin Oncol (R Coll Radiol). 2010 Aug;22(6):486-97. doi: 10.1016/j.clon.2010.03.013. Epub 2010 Apr 24. Clin Oncol (R Coll Radiol). 2010. PMID: 20418080 Free PMC article. Review.
Anaplastic thyroid carcinoma ranges from 1.3 to 9.8% of all thyroid cancers globally. ...Although more aggressive radiotherapy has reduced locoregional recurrences, the median overall survival has not improved in over 50 years. ...
Anaplastic thyroid carcinoma ranges from 1.3 to 9.8% of all thyroid cancers globally. ...Although more aggressiv …
When thyroid carcinoma goes bad: a morphological and molecular analysis.
Papp S, Asa SL. Papp S, et al. Head Neck Pathol. 2015 Mar;9(1):16-23. doi: 10.1007/s12105-015-0619-z. Epub 2015 Mar 25. Head Neck Pathol. 2015. PMID: 25804379 Free PMC article. Review.
Mutational analyses in the past decade have delineated the molecular alterations responsible for thyroid carcinogenesis and progression, allowing greater sub-classification and prognostication of thyroid carcinomas. This review article highlights important ag …
Mutational analyses in the past decade have delineated the molecular alterations responsible for thyroid carcinogenesis and progressi …
Anaplastic thyroid carcinoma.
Haigh PI. Haigh PI. Curr Treat Options Oncol. 2000 Oct;1(4):353-7. doi: 10.1007/s11864-000-0051-8. Curr Treat Options Oncol. 2000. PMID: 12057160 Review.
Anaplastic thyroid carcinoma (ATC) is a rare, highly aggressive tumor characterized by rapid growth that causes death soon after diagnosis. ...Surgical extirpation with radical organ resection is associated with high morbidity, and, although an aggressive sur …
Anaplastic thyroid carcinoma (ATC) is a rare, highly aggressive tumor characterized by rapid growth that causes death s …
Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases.
Xu B, David J, Dogan S, Landa I, Katabi N, Saliba M, Khimraj A, Sherman EJ, Tuttle RM, Tallini G, Ganly I, Fagin JA, Ghossein RA. Xu B, et al. Histopathology. 2022 Jan;80(2):322-337. doi: 10.1111/his.14550. Epub 2021 Oct 7. Histopathology. 2022. PMID: 34449926 Free PMC article.
AIMS: We aimed to study the clinicopathological and molecular features of high-grade non-anaplastic thyroid carcinomas (HGTCs), a carcinoma with a prognosis intermediate between those of well-differentiated carcinoma and anaplastic car …
AIMS: We aimed to study the clinicopathological and molecular features of high-grade non-anaplastic thyroid carcinomas (HGTCs) …
New Insights into Immune Cells and Immunotherapy for Thyroid Cancer.
Tao Y, Li P, Feng C, Cao Y. Tao Y, et al. Immunol Invest. 2023 Nov;52(8):1039-1064. doi: 10.1080/08820139.2023.2268656. Epub 2023 Nov 24. Immunol Invest. 2023. PMID: 37846977 Review.
Differentiated thyroid cancer (DTC) is the most common subtype and has a good prognosis. However, advanced DTC patients with recurrence, metastasis and iodine refractoriness, as well as more aggressive subtypes such as poorly differentiated thyroid can …
Differentiated thyroid cancer (DTC) is the most common subtype and has a good prognosis. However, advanced DTC patients with …
Genetics and epigenetics of sporadic thyroid cancer.
Vu-Phan D, Koenig RJ. Vu-Phan D, et al. Mol Cell Endocrinol. 2014 Apr 5;386(1-2):55-66. doi: 10.1016/j.mce.2013.07.030. Epub 2013 Aug 8. Mol Cell Endocrinol. 2014. PMID: 23933154 Free PMC article. Review.
Thyroid carcinoma is the most common endocrine malignancy, and although the disease generally has an excellent prognosis, therapeutic options are limited for patients not cured by surgery and radioiodine. Thyroid carcinomas commonly contain one of a sm …
Thyroid carcinoma is the most common endocrine malignancy, and although the disease generally has an excellent prognosis …
170 results